ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Harmony Biosciences Holdings, Inc. ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 27.07%
- Healthy long term growth as Net Sales has grown by an annual rate of 49.81% and Operating profit at 62.18%
- Company has a low Debt to Equity ratio (avg) at times
2
Positive results in Sep 25
- OPERATING CASH FLOW(Y) Highest at USD 297.61 MM
- INTEREST COVERAGE RATIO(Q) Highest at 1,973.35
- RAW MATERIAL COST(Y) Fallen by 1.65% (YoY)
3
With ROE of 23.40%, it has a very attractive valuation with a 1.94 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -15.15%, its profits have risen by 48% ; the PEG ratio of the company is 0.2
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Harmony Biosciences Holdings, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Harmony Biosciences Holdings, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Harmony Biosciences Holdings, Inc.
-15.15%
-0.09
52.57%
S&P 500
17.78%
0.92
19.35%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
49.81%
EBIT Growth (5y)
62.18%
EBIT to Interest (avg)
6.67
Debt to EBITDA (avg)
0.20
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
0.81
Tax Ratio
22.55%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
45.85%
ROE (avg)
27.07%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
1.94
EV to EBIT
5.14
EV to EBITDA
4.64
EV to Capital Employed
2.74
EV to Sales
1.48
PEG Ratio
0.18
Dividend Yield
NA
ROCE (Latest)
53.26%
ROE (Latest)
23.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 297.61 MM
INTEREST COVERAGE RATIO(Q)
Highest at 1,973.35
RAW MATERIAL COST(Y)
Fallen by 1.65% (YoY
CASH AND EQV(HY)
Highest at USD 1,237.86 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -53.35 %
NET SALES(Q)
Highest at USD 239.46 MM
OPERATING PROFIT(Q)
Highest at USD 71.45 MM
PRE-TAX PROFIT(Q)
Highest at USD 67.49 MM
NET PROFIT(Q)
Highest at USD 50.87 MM
EPS(Q)
Highest at USD 0.87
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Harmony Biosciences Holdings, Inc.
Operating Cash Flow
Highest at USD 297.61 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Interest Coverage Ratio
Highest at 1,973.35
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales
Highest at USD 239.46 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 239.46 MM has Grown at 28.71%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 71.45 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD 67.49 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 50.87 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.87
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 1,237.86 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -53.35 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by 1.65% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
